Course of Borrelia burgdorferi DNA shedding in urine after treatment

Acta Dermato-Venereologica

Volumn 87, Issue 1, 2007, Pages 39-42

  Aberer, Elisabeth ^a   Bergmann, Andreas R ^a   Derler, Anna Maria ^b   Schmidt, Bruno ^c  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c GENERAL HOSPITAL LINZ   (Austria)

Author keywords

Acrodermatitis chronica atrophicans; Erythema migrans; Lyme borreliosis; PCR

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA;

ACRODERMATITIS; ADULT; AGED; ARTICLE; BORRELIA BURGDORFERI; CHILD; CONTROLLED STUDY; ERYTHEMA CHRONICUM MIGRANS; FEMALE; HUMAN; HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYMPTOMATOLOGY; URINALYSIS; VIRUS SHEDDING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BORRELIA BURGDORFERI; CHILD; DNA, BACTERIAL; ERYTHEMA CHRONICUM MIGRANS; FEMALE; HUMANS; LYME DISEASE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 33846852881     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0172     Document Type: Article

References (24)

1. Wilske B, Zoeller L, Brade V, Eiffert H, Göbel UB, Stanek G. Lyme Borreliose. In: Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik MiQ 12, 20; München, Lena, Urban & Fischer, 2001: 23-25.
2. Stanek G, O'Conell SO, Cimmino M, Aberer E, Kristoferitsch W, Granström M, et al. European concerted action of risk assessment in Lyme borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 1996; 108: 741-747.
3. Nowakowski J, Schwartz I, Liveris D, Wang G, Aguero-Rosenfeld ME, Girao G, et al. Laboratory diagnostic techniques for patients with early Lyme Disease associated with erythema migrans: a comparison of different techniques. Clin Infect Dis 2001; 33: 2023-2027.
4. Pierer K, Koeck T, Freidl W, Stuenzner D, Pierer G, Marth E, et al. Prevalence of antibodies to B. burgdorferi flagellin in Styrian blood donors. Zbl Bakt 1993; 279: 239-243.
5. Schmidt BL. PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Rev 1997; 10: 185-201.
6. Lebech AM, Hansen K, Brandrup F, Clemmensen O, Halkier-Sorensen L. Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis. Mol Diagn 2000; 5: 139-150.
7. Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC. Detection of Borrelia burdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994; 330: 229-234.
8. Priem S, Rittig MG, Kamradt T, Burmester GR, Krause A. An optimized PCR leads to rapid and highly sensitive detection of Borrelia burgdorferi in patients with Lyme borreliosis. J Clin Microbiol 1997; 35: 685-690.
9. Schnarr S, Putschky N, Jendro MC, Zeidler H, Hammer M, Kuipers JG, Wollenhaupt J. Clamydia and Borrelia DNA in synovial fluid of patients with early undifferentiated oligoarthritis. Arthritis Rheum 2001; 44: 2679-2685.
10. Exner MM, Lewinski MA. Isolation and detection of Borrelia burgdorferi DNA from cerebral spinal fluid, synovial fluid, urine, and ticks using the Roche MagNA Pure system and real-time PCR. Diagn Microbiol Infect Dis 2003; 46: 235-240.
11. Schmidt BL, Aberer E, Stockenhuber C, Klade H, Breier F, Luger A. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in the urine and breast milk of patients with Lyme borreliosis. Diagn Microbiol Infect Dis 1995; 21: 121-128.
12. Bergmann AR, Schmidt BL, Derler AM, Aberer E. Importance of sample preparation for the molecular diagnosis of Lyme borreliosis from urine. J Clin Microbiol 2002; 40: 4581-4584.
13. Goodman JE, Jurkovich P, Kramber JM, Johnson RC. Molecular detection of persistent Borrelia burgdorferi in the urine of patients with active Lyme disease. Inf Immun 1991; 59: 269-278.
14. Grignolo MC, Buffrini L, Monteforte P, Rovetta G. Reliability of a polymerase chain reaction (PCR) technique in the diagnosis of Lyme borreliosis. Minerva Med 2001; 92: 29-33.
15. Pauluzzi P, Bonin S, Gonzalez Inchaurraga MA, Stanta G, Trevisan G. Detection of spirochaetal DNA simultaneously in skin biopsies, peripheral blood and urine from patients with erythema migrans. Acta Derm Venereol 2004; 84: 106-110.
16. Pleyer U, Priem S, Bergmann L, Burmester G, Hartmann C, Krause A. Detection of Borrelia burgdorferi DNA in urine of patients with ocular Lyme borreliosis. Br J Ophthalmol 2001; 85: 552-555.
17. Mercier G, Burckel A, Lucotte G. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in urine specimen of patients with erythema migrans lesions. Mol Cell Probes 1997; 11: 89-94.
18. Schmidt BL, Muellegger RR, Stockenhuber C. Detection of Borrelia burgdorferi-specific DNA in urine specimens from patients with erythema migrans before and after antibiotic therapy. J Clin Microbiol 1996; 34: 1359-1363.
19. Wicher K, Abbruscato F, Wicher V, Collins DN, Auger I, Horowitz HW. Identification of persistent infection in experimental syphilis by PCR. Infect Immun 1998; 66: 2509-2513.
20. Dunlop EM. Survival of treponemes after treatment: comments, clinical conclusions, and recommendations. 1986. Sex Transm Infect 2000; 76: 1: S38.
21. Weber K. Treatment failure in erythema migrans - a review. Infection 1996; 24: 73-75.
22. Kuiper H, van Dam AP, Moll van Charante AW, Nauta NP, Dankert J. One year follow-up study to assess the prevalence and incidence of Lyme borreliosis among Dutch forestry workers. Eur J Clin Microbiol Infect Dis 1993; 12: 413-418.
23. Karch H, Huppertz HI, Böhme M, Schmidt H, Wiebecke D, Schwarzkopf A. Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B. burgdorferi-specific antibodies. J Clin Microbiol 1994; 32: 2312-2314.
24. Wagner EM, Schmidt B, Bergmann AR, Derler AM, Aberer E. Inability of one-step real-time PCR to detect B. burgdorferi DNA in urine. J Clin Microbiol 2004; 42: 93.